One World Products Inc Quick Ratio (OWPC) starting from the third quarter 2025 to third quarter 2024, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


One World Products Inc   (OWPC)

One World Products Inc 's Quick Ratio

OWPC's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


One World Products Inc 's Cash & cash equivalent grew by 1138.49 % in the Q3 2025 sequentially, faster than Current Liabilities, this led to improvement in One World Products Inc 's Quick Ratio to 0.04, Quick Ratio remained below One World Products Inc average.

Within Major Pharmaceutical Preparations industry 477 other companies have achieved higher Quick Ratio than One World Products Inc in third quarter 2025. While Quick Ratio total ranking in the third quarter 2025 has deteriorated compared to the prior quarter from 3874 to 4211.

Explain Quick Ratio?
How much Cash & cash equivalents OWPC´s has?
What are OWPC´s Current Liabilities?




OWPC Quick Ratio (Sep 30 2025)
Q3
(Jun 30 2025)
Q2
(Mar 31 2025)
Q1
(Dec 31 2024)
Q4
(Sep 30 2024)
Q3
Y / Y Current Liabilities Change 30.23 % 17.06 % 71.29 % 6.41 % -27.55 %
Y / Y Cash & cash equivalent Change 1.19 % -96.96 % -99.71 % -50.47 % 75.12 %
Quick Ratio MRQ 0.04 0 0 0.01 0.05
OWPC's Total Ranking # 4211 # 3874 # 4286 # 4368 # 3744
Seq. Current Liabilities Change 24.34 % 1.45 % 6.54 % -3.09 % 11.77 %
Seq. Cash & cash equivalent Change 1138.49 % 3671.47 % -99.15 % -74.52 % -62.74 %



Quick Ratio third quarter 2025 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 478
Healthcare Sector # 943
Overall Market # 4211


Quick Ratio Statistics
High Average Low
1.25 0.29 0
(Mar 31 2019)   (Mar 31 2025)




Financial Statements
One World Products Inc 's Current Liabilities $ 4 Millions Visit OWPC's Balance sheet
One World Products Inc 's Cash & cash equivalent $ 0 Millions Visit OWPC's Balance sheet
Source of OWPC's Sales Visit OWPC's Sales by Geography


Cumulative One World Products Inc 's Quick Ratio

OWPC's Quick Ratio for the trailling 12 Months

OWPC Quick Ratio

(Sep 30 2025)
12 Months
(Jun 30 2025)
12 Months
(Mar 31 2025)
12 Months
(Dec 31 2024)
12 Months
(Sep 30 2024)
12 Months
Y / Y Current Liabilities TTM Growth 27.67 % 6.87 % -2.92 % -20.57 % -16.71 %
Y / Y Cash & cash equivalent TTM Growth -72.73 % -70.41 % 23.38 % 44.35 % -56.95 %
Quick Ratio TTM 0.02 0.02 0.05 0.07 0.07
Total Ranking TTM # 3324 # 3213 # 3482 # 3732 # 3620
Seq. Current Liabilities TTM Growth 7.47 % 3.92 % 12.4 % 1.71 % -10.04 %
Seq. Cash & cash equivalent TTM Growth 0.89 % -66.03 % -16.02 % -5.24 % 9.48 %


On the trailing twelve months basis In Spite of the growth in Current Liabilities in the Q3 2025 to $4.26 millions, cumulative Quick Ratio remained unchanged at 0.02 below the One World Products Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 426 other companies have achieved higher Quick Ratio than One World Products Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2025 from 3213 to 3324.

Explain Quick Ratio?
How much Cash & cash equivalents OWPC´s has?
What are OWPC´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 427
Healthcare Sector # 886
Within the Market # 3324


trailing twelve months Quick Ratio Statistics
High Average Low
0.99 0.27 0.02
(Mar 31 2022)   (Sep 30 2025)




Companies with similar Quick Ratio in the quarter ending Sep 30 2025, within Major Pharmaceutical Preparations Industry Quick RatioSep 30 2025 MRQ Cash & cash equivalentSep 30 2025 MRQ Current Liabilities
Jaguar Health Inc   0.10 $ 3.527  Millions$ 36.122  Millions
Neonc Technologies Holdings Inc   0.10 $ 1.513  Millions$ 15.588  Millions
Citius Pharmaceuticals Inc   0.09 $ 4.252  Millions$ 44.915  Millions
Neurosense Therapeutics Ltd  0.08 $ 0.213  Millions$ 2.516  Millions
Galectin Therapeutics Inc   0.08 $ 11.525  Millions$ 136.445  Millions
Cv Sciences Inc   0.08 $ 0.381  Millions$ 4.539  Millions
Rain Enhancement Technologies Holdco Inc   0.08 $ 0.237  Millions$ 2.896  Millions
Gridai Technologies Corp  0.08 $ 2.517  Millions$ 33.516  Millions
Polomar Health Services, Inc.  0.07 $ 0.048  Millions$ 0.672  Millions
Summit Therapeutics Inc   0.07 $ 4.870  Millions$ 70.933  Millions
Zyversa Therapeutics Inc   0.05 $ 0.697  Millions$ 12.766  Millions
Northwest Biotherapeutics Inc  0.05 $ 4.560  Millions$ 87.905  Millions
Blue Water Vaccines Inc  0.05 $ 0.837  Millions$ 16.303  Millions
Scienture Holdings Inc   0.05 $ 0.356  Millions$ 7.351  Millions
The Greater Cannabis Company Inc   0.04 $ 0.021  Millions$ 0.483  Millions
China Pharma Holdings Inc  0.04 $ 0.268  Millions$ 6.623  Millions
One World Products Inc   0.04 $ 0.169  Millions$ 4.258  Millions
Abvc Biopharma Inc   0.04 $ 0.257  Millions$ 6.508  Millions
Lunai Bioworks Inc   0.04 $ 0.625  Millions$ 16.963  Millions
Scorpius Holdings inc   0.03 $ 0.601  Millions$ 22.196  Millions
NIKA PHARMACEUTICALS, INC  0.02 $ 0.006  Millions$ 0.284  Millions
Oncotelic Therapeutics Inc   0.02 $ 0.409  Millions$ 20.080  Millions
Regen Biopharma Inc   0.01 $ 0.070  Millions$ 5.549  Millions
Provectus Biopharmaceuticals Inc   0.01 $ 0.072  Millions$ 6.472  Millions
Aditxt Inc   0.01 $ 0.163  Millions$ 17.054  Millions
Semnur Pharmaceuticals Inc   0.01 $ 0.085  Millions$ 10.032  Millions

Date modified: 2026-09-26T07:20:43+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.